Rafael de Llorens

2.8k total citations
61 papers, 2.4k citations indexed

About

Rafael de Llorens is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rafael de Llorens has authored 61 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 29 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rafael de Llorens's work include Glycosylation and Glycoproteins Research (19 papers), HER2/EGFR in Cancer Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Rafael de Llorens is often cited by papers focused on Glycosylation and Glycoproteins Research (19 papers), HER2/EGFR in Cancer Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Rafael de Llorens collaborates with scholars based in Spain, United States and Ireland. Rafael de Llorens's co-authors include Rosa Peracaula, Pauline M. Rudd, Sílvia Barrabés, Ariadna Sarrats, Claudi M. Cuchillo, Marie‐Hélène Le Du, Rosa Núria Aleixandre, Esther Llop, Manel Ramírez and Radka Saldova and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Rafael de Llorens

61 papers receiving 2.3k citations

Peers

Countries citing papers authored by Rafael de Llorens

Since Specialization

Citations

This map shows the geographic impact of Rafael de Llorens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael de Llorens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael de Llorens more than expected).

Fields of papers citing papers by Rafael de Llorens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael de Llorens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael de Llorens. The network helps show where Rafael de Llorens may publish in the future.

Co-authorship network of co-authors of Rafael de Llorens

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael de Llorens. A scholar is included among the top collaborators of Rafael de Llorens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael de Llorens. Rafael de Llorens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients’ Sera 2022 ·Biomedicines ·(unknown), Pedro Enrique Guerrero, María Ortiz, Dúnia Pérez del Campo, Ernesto Castro, A. García, Esther Fort, Rafael de Llorens, Radka Saldova, Esther Llop, Rosa Peracaula	2
2	Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion 2020 ·International Journal of Molecular Sciences ·Pedro Enrique Guerrero, (unknown), Bin Sheng Wong, Anna Massaguer, Neus Martínez‐Bosch, Rafael de Llorens, Pilar Navarro, Κωνσταντίνος Κωνσταντόπουλος, Esther Llop, Rosa Peracaula	36
3	Synthesis and Biological Evaluation of Ru(II) and Pt(II) Complexes Bearing Carboxyl Groups as Potential Anticancer Targeted Drugs 2017 ·Inorganic Chemistry ·María Ángeles Martínez, (unknown), Anna Massaguer, Lucı́a Santos, Juan Ángel Organero, (unknown), Rafael de Llorens, (unknown), Lídia Feliu, Marta Planas, Ana M. Rodrı́guez, Blanca R. Manzano, Gustavo Espino, Félix A. Jalón	45
4	Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer 2017 ·Clinica Chimica Acta ·Sílvia Barrabés, Esther Llop, (unknown), Manel Ramírez, Rosa Núria Aleixandre, Antoinette S. Perry, Rafael de Llorens, Rosa Peracaula	14
5	Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology 2016 ·PLoS ONE ·María José Ferri, Marc Sáez, Joan Figueras, Esther Fort, M Sàbat, Santiago López‐Ben, Rafael de Llorens, Rosa Núria Aleixandre, Rosa Peracaula	29
6	Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin 2015 ·Clinica Chimica Acta ·Meritxell Balmaña, Ariadna Sarrats, Esther Llop, Sílvia Barrabés, Radka Saldova, María José Ferri, Joan Figueras, Esther Fort, Rafael de Llorens, Pauline M. Rudd, Rosa Peracaula	47
7	Identification of Caveolin-1 as a Potential Causative Factor in the Generation of Trastuzumab Resistance in Breast Cancer Cells 2013 ·Journal of Cancer ·Sreeja C. Sekhar, Tomonari Kasai, Ayano Satoh, (unknown), Akifumi Mizutani, Hiroshi Murakami, Bishoy El‐Aarag, (unknown), Anna Massaguer, Rafael de Llorens, Masaharu Seno	33
8	α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues 2013 ·The International Journal of Biochemistry & Cell Biology ·Marta Pérez-Garay, Beatriz Arteta, Esther Llop, (unknown), Lluı́s Pagès, María Ortiz, María José Ferri, Carme de Bolós, Joan Figueras, Rafael de Llorens, Fernando Vidal‐Vanaclocha, Rosa Peracaula	74
9	Somatostatin Subtype-2 Receptor-Targeted Metal-Based Anticancer Complexes 2012 ·Bioconjugate Chemistry ·Flavia Barragán, (unknown), Irene Gómez‐Pinto, (unknown), Peter J. Sadler, Rafael de Llorens, Virtudes Moreno, Carlos González, Anna Massaguer, Vicente Marchán	49
10	Effect of sialic acid content on glycoprotein pI analyzed by two‐dimensional electrophoresis 2010 ·Electrophoresis ·Sílvia Barrabés, Ariadna Sarrats, Esther Fort, Rafael de Llorens, Pauline M. Rudd, Rosa Peracaula	46
11	α2,3-Sialyltransferase ST3Gal III Modulates Pancreatic Cancer Cell Motility and Adhesion In Vitro and Enhances Its Metastatic Potential In Vivo 2010 ·PLoS ONE ·Marta Pérez-Garay, Beatriz Arteta, Lluı́s Pagès, Rafael de Llorens, Carme de Bolós, Fernando Vidal‐Vanaclocha, Rosa Peracaula	73
12	Differential percentage of serum prostate‐specific antigen subforms suggests a new way to improve prostate cancer diagnosis 2009 ·The Prostate ·Ariadna Sarrats, Josep Comet, Glòria Tabarés, Manel Ramírez, Rosa Núria Aleixandre, Rafael de Llorens, Rosa Peracaula	34
13	Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: The importance of scheduling 2008 ·International Journal of Oncology ·Cristina Oliveras‐Ferraros, Alejandro Vázquez‐Martín, Rámón Colomer, Rafael de Llorens, Joan Brunet, Javier A. Menéndez	33
14	Study by HPLC-MS of the interaction of platinum antitumor complexes with potato carboxypeptidase inhibitor (PCI) 2008 ·Bioorganic & Medicinal Chemistry ·Alberto Martínez, Virtudes Moreno, (unknown), Rafael de Llorens, Francesc Avilés, Júlia Lorenzo	2
15	Free PSA forms in prostatic tissue and sera of prostate cancer patients: Analysis by 2-DE and western blotting of immunopurified samples 2007 ·Clinical Biochemistry ·Glòria Tabarés, Klaus Jung, (unknown), Carsten Stephan, Michael Lein, Rosa Peracaula, Rafael de Llorens, Wolfgang Hoesel	23
16	Train A, an RNase A-Like Protein Without RNase Activity, Is Secreted and Reabsorbed by the Same Epididymal Cells under Testicular Control1 2004 ·Biology of Reproduction ·Sandrine Castella, Hélène Bénédetti, Rafael de Llorens, Jean‐Louis Dacheux, Françoise Dacheux	24
17	Cloning, expression and purification of human epidermal growth factor using different expression systems 2003 ·Journal of Chromatography B ·Lucile Solér, Juan Cedano, Enrique Querol, Rafael de Llorens	26
18	Growth inhibition of mammalian cells by eosinophil cationic protein 2002 ·European Journal of Biochemistry ·Takashi Maeda, Midori Kitazoe, Hiroko Tada, Rafael de Llorens, David S. Salomon, Masakazu Ueda, Hidenori Yamada, Masaharu Seno	50
19	Protein similarities beyond disulphide bridge topology 1998 ·Journal of Molecular Biology ·José Manuel Mas, Patrick Aloy, Marc A. Martı́-Renom, Baldomero Oliva, Carmen Blanco‐Aparicio, (unknown), Rafael de Llorens, Enrique Querol, Francesc Avilés	31
20	Expression of acinar and ductal products in capan-1 cells growing in synthetic serum and serum-free media 1994 ·Cancer ·E. Fernández, (unknown), Marsha L. Frazier, Rafael de Llorens, Claudi M. Cuchillo	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact